Expression of excision repair cross-complementation group 1 in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy | Zendy

Chuan Shen | Zendy; LingLing Chen | Zendy; Jiangtao Fu | Zendy; Hongbin Lin | Zendy

Open Access

Expression of excision repair cross-complementation group 1 in locoregionally advanced nasopharyngeal carcinoma treated with cisplatin-based induction chemotherapy

Author(s) -

Chuan Shen,

LingLing Chen,

Jiangtao Fu,

Hongbin Lin

Publication year - 2016

Publication title -

journal of cancer research and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.475

H-Index - 39

eISSN - 0973-1482

pISSN - 1998-4138

DOI - 10.4103/0973-1482.191636

Subject(s) - cisplatin , nasopharyngeal carcinoma , induction chemotherapy , medicine , chemotherapy , complementation , oncology , cancer research , biology , gene , radiation therapy , genetics , phenotype

The purpose of this study was to evaluate the expression of excision repair cross-complementation group 1 (ERCC1) in locoregionally advanced nasopharyngeal carcinoma (NPC) treated with cisplatin-based induction chemotherapy.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research